Neelam, A. and Kanaki, A. (2021) “Efficacy and safety of remogliflozin etabonate in type 2 diabetes mellitus patients in a tertiary care hospital”, International Journal of Basic & Clinical Pharmacology, 10(4), pp. 353–356. doi: 10.18203/2319-2003.ijbcp20211014.